🥇 First rule of investing? Know when to save! Up to 55% off InvestingPro before BLACK FRIDAYCLAIM SALE

GE Healthcare sees mid-single-digit revenue growth over medium term

Published 12/08/2022, 09:57 AM
Updated 12/08/2022, 01:01 PM
© Reuters. FILE PHOTO: A logo is displayed on a GE digital anesthesia carestation as U.S. Vice President Mike Pence (not pictured) visits a GE Healthcare manufacturing facility during the global coronavirus disease (COVID-19) outbreak in Madison, Wisconsin, U.S. Apr
BARC
-
GE
-

By Khushi Mandowara and Leroy Leo

(Reuters) -General Electric Co's healthcare division is aiming to have a medium-term organic revenue growth in the mid-single-digits, the unit's Chief Executive Officer Peter Arduini said at an investor day conference on Thursday.

GE Healthcare, which will be spun off into a separate listed company early next year, expects an aging population, chronic diseases and a rise in the middle class in many emerging markets to drive growth targets for the company.

China, which accounts for about 15% of total GE Healthcare sales, would also help drive growth as there is a pent-up demand in the market, Arduini said.

Besides organic growth, the company will also look at "tuck-in" acquisitions to boost its business, on similar lines as its $1.45-billion buyout of ultrasound device maker BK Medical last year, Chief Financial Officer Helmut Zodl said.

GE Healthcare also expects medium-term adjusted core earnings margin to be close to 20%.

Zodl highlighted challenges such as macroeconomic factors, supply chain challenges, restructuring action undertaken in 2022 along with planned investment in research and development which may weigh on its core earnings margin.

The new company's medium-term goal for core earnings margin "should be well received in light of concerns around the R&D step-up that might be needed", wrote Barclays (LON:BARC) analyst Julian Mitchell in a note.

The healthcare company had revenue of around $18 billion last year, with about half of it from recurring sources, GE Healthcare said in a presentation.

General Electric (NYSE:GE) in November last year announced it would split into three publicly traded units focused on healthcare, aviation and energy as it aimed to simplify business and pare down debt.

© Reuters. FILE PHOTO: A logo is displayed on a GE digital anesthesia carestation during the global coronavirus disease (COVID-19) outbreak in Madison, Wisconsin, U.S. April 21, 2020. REUTERS/Daniel Acker

GE Healthcare will operate imaging and ultrasound devices, patient care solutions and pharmaceutical diagnostics businesses.

The healthcare unit is expected to complete its spin off on Jan. 3, with public trading being set from the next day.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.